In addition, while significantly increased expression of LGALS1 was seen in AP/BP-MPN and a clear correlation found between high expression of LGALS1 and poor survival in de novo AML associated with inflammatory signalling, further work is required to establish a mechanistic role for galectin-1 in leukemic progression. This evidence concerns the gene LGALS1 and myeloproliferative disorder.